Abstract: A catheter system may include a catheter adapter and a catheter extending distally from the catheter adapter. The catheter system may include a needle assembly, which may include a plug, an outer housing, and an introducer needle. An outer surface of the plug may include multiple grooves, which may be in fluid communication with the introducer needle and configured to receive blood flashback. The grooves may include a first groove having a first surface-area-to-volume ratio, and a second groove having a second surface-area-to-volume ratio. The first surface-area-to-volume ratio may be less than the second surface-area-to-volume ratio. The first groove may have a greater volume than the second groove. The outer housing may seal a top of the first groove and a top of the second groove to prevent blood from flowing out the top of the first groove and the top of the second groove.

Abstract: An encoding method includes dividing a to-be-encoded time-domain signal into a low band signal and a high band signal, performing encoding on the low band signal to obtain a low frequency encoding parameter, performing encoding on the high band signal to obtain a high frequency encoding parameter, obtaining a synthesized high band signal, performing short-time post-filtering processing on the synthesized high band signal to obtain a short-time filtering signal, and calculating a high frequency gain based on the high band signal and the short-time filtering signal.

Abstract: This application discloses a downmixed signal calculation method and apparatus. The method includes: when a current frame or a previous frame of the current frame of a stereo signal is not a switching frame and a residual signal in the current frame or the previous frame does not need to be encoded, obtaining a second downmixed signal in the current frame and a downmix compensation factor of the current frame, correcting the second downmixed signal in the current frame based on the downmix compensation factor of the current frame, to obtain the first downmixed signal in the current frame and determining the first downmixed signal in the current frame as a downmixed signal in the current frame in a preset frequency band.

Abstract: This disclosure provides methods and apparatuses relating to device control right obtaining. One method is applied to a system including a first device and a second device. The first device detects that the second device approaches the first device, the first device sends a first key to the second device. After receiving the first key, the second device encrypts a control instruction by using the first key, where the control instruction is used to control the first device. The second device sends the encrypted control instruction to the first device, and the first device decrypts the encrypted control instruction to obtain the control instruction and executes the control instruction.

Abstract: The present invention provides a method and an apparatus for determining travel path bound, a vehicle, a storage medium and a terminal. The method includes: under a first coordinate system, according to contour point positions respectively corresponding to a vehicle and an obstacle in a path trajectory, determining a collision-anticipated overlap corner position; based on a trajectory normal of the vehicle and the overlap corner position, determining a contour corner overlap line and a decision corner reference line; if a first intersection position between the contour corner overlap line and the decision corner reference line is not located on the contour edge, based on the overlap corner position, the decision corner reference line and contour corner positions on the contour corner overlap line, determining a collision-avoiding distance of the vehicle; under a second coordinate system, based on the collision-avoiding distance, generating a travel path bound.

Abstract: M audio signals are obtained by processing an audio signal by M virtual speakers; M first HRTFs and M second HRTFs are obtained, where the M first HRTFs corresponding to a left ear position, and the M second HRTFs corresponding to a right ear position; high-band impulse responses of some of the M first HRTFs are modified to obtain modified first target HRTFs, and high-band impulse responses of some of the M second HRTFs are modified to obtain modified second target HRTFs; a first target audio signal corresponding to the left ear position is obtained based on the modified first target HRTFs and un-modified first HRTFs, and the M audio signals; and a second target audio signal corresponding to the right ear position is obtained based on the modified second HRTFs, un-modified second target HRTFs, and the M audio signals.

Abstract: In a stereo encoding method, a channel combination encoding solution of a current frame is first obtained, and then a quantized channel combination ratio factor of the current frame and an encoding index of the quantized channel combination ratio factor are obtained based on the obtained channel combination encoding solution, so that an obtained primary channel signal and secondary channel signal of the current frame meet a characteristic of the current frame.

Abstract: A method for obtaining a higher-order ambisonics (HOA) coefficient includes obtaining location information of a virtual speaker on a preset spherical surface, where the preset spherical surface includes M circles of longitude and N circles of latitude, and obtaining, based on the location information and a preset reference trigonometric function table, a trigonometric function value corresponding to the location information, where the reference trigonometric function table includes an elevation trigonometric function table and/or an azimuth trigonometric function table, and obtaining an HOA coefficient for the virtual speaker based on the trigonometric function value corresponding to the location information.

Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions comprising these compounds and methods of using these compounds for treating a metabolic disease or liver condition. The present invention relates generally to compounds and pharmaceutical compositions useful as 17?-HSD13 inhibitors. Specifically, the present invention relates to compounds useful as inhibitors of 17?-HSD13 and methods for their preparation and use.

Abstract: This application provides a method and an apparatus for determining a virtual speaker set. The method for determining a virtual speaker set includes: determining a target virtual speaker from F preset virtual speakers based on a to-be-processed audio signal, where each of the F virtual speakers corresponds to S virtual speakers, F is a positive integer, and S is a positive integer greater than 1; and obtaining, from a preset virtual speaker distribution table, respective position information of S virtual speakers corresponding to the target virtual speaker, where the virtual speaker distribution table includes position information of K virtual speakers, the position information includes an elevation angle index and an azimuth angle index, K is a positive integer greater than 1, F?K, and F×S?K. This application can improve audio signal playback effect.

Abstract: A display apparatus and a driving method therefor. The driving method includes: determining a gaze area and a non-gaze area of a user on a display apparatus in real time; and driving the gaze area for image displaying at a first resolution, and driving the non-gaze area for image displaying at a second resolution, wherein the first resolution is higher than the second resolution. By means of the display apparatus, image resolution can be adjusted according to different areas, so as to realize high-resolution image display in a display area at which a user gazes and realize low-resolution image display in other areas, thereby reducing power consumption and achieving reasonable allocation of resources on the premise of ensuring the user experience.

Abstract: Fluid flow devices including a fluid passage for regulating movement of a fluid therethrough, including flow restriction devices having first and second passages that can regulate a fluid flow in a first direction through the device and can regulate a fluid flow in a second direction through the device, and fluid flow restriction devices that can include a first connector having an internal surface defining an inner lumen, a second connector coupled to an end of the first connector, a cannula mounted in the inner lumen extending into the second connector, a lumen of the cannula may define a first flowpath along which a fluid flows into a fluid collection device, and an annulus may be defined between an outer surface of the cannula and the internal surface of the first connector, the annulus may define a second flowpath along which a fluid flows into a catheter assembly.

Abstract: A multi-stage adjusting damping valve as well as a shock absorber and suspension system using the damping valve are provided. The multi-stage adjusting damping valve comprises a throttle valve, an overflow valve and a multi-stage pilot valve. The multi-stage pilot valve comprises a mechanical regulating valve and a plurality of high-speed switch electromagnetic valves having different throttle hole diameters. The damping valve is connected between a rod cavity and an oil storage cavity of the shock absorber by means of a middle cavity, and the multi-stage damping rapid regulation of the shock absorber is achieved through high-frequency opening and closing of a high-speed switching electromagnetic valve, and in comparison, the machining precision, the manufacturing cost and the control and calibration difficulty of the present disclosure are greatly reduced.

Abstract: The present invention provides a composition comprising a compound of formula (I) or a physiologically acceptable salt thereof, in which the compound of formula (I) or a physiologically acceptable salt thereof has a HPLC purity of ?90%; wherein R1, R2, X and n are as defined herein. The present invention further provides use of the composition according to the present invention for preparing and/or purifying a composition comprising a salt of the compound of formula (I), and a method for treating a disease caused by a coronavirus which comprises administering the composition of the present invention to a subject. The composition of the present invention comprises the compound of formula (I) with high purity, and has good fluidity and anti-caking property; moreover, the claimed composition comprising the compound of formula (I)) with high purity is more suitable for preparing a composition comprising a salt of the compound of formula (I) with higher purity.

Abstract: A session border controller (SBC) system includes an SBC signaling and media processing module and an SBC signaling access module. The SBC signaling access module is configured to: receive signaling sent by a terminal and forward the signaling to the SBC signaling and media processing module; and when the terminal is disconnected from a network during a call, re-register and reconnect the terminal, and after the terminal is reconnected, receive an information request from the terminal during the call and forward the information request to the SBC signaling and media processing module. The SBC signaling and media processing module is configured to: process the signaling and media streams from the terminal, and when the terminal is disconnected from the network during the call, learn, based on the information request, a transmission link for communication with the terminal after the terminal is reconnected upon the disconnection from the network.

Abstract: An IV access device can include a needle hub that incorporates a flash chamber. The flash chamber can be used to provide visual confirmation of proper catheter placement within a vein. The flash chamber can include a path-defining structure to facilitate identifying whether blood is continually flowing into the flash chamber. The flash chamber may also be removable from the needle hub. In some cases, the needle hub may include a paddle grip that facilitates insertion of the catheter and separation of the needle hub from the catheter adapter.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: which inhibit the Apoptosis signal-regulating kinase 1 (ASK-1), which is associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-1 related disease. The invention also relates to methods of treating an ASK-1 related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Abstract: A method for semantic recognition includes: in response to performing semantic analysis on information acquired by a terminal, a sentence to be processed is acquired. Word recognition is performed on the sentence to be processed, to obtain a plurality of words and part-of-speech information thereof. A target set update operation is determined with a pre-trained word processing model, according to a word to be processed in the set of words to be processed and part-of-speech information of the word to be processed. If a dependency relationship corresponding to the target set update operation is a first dependency relationship, through each of the plurality of preset set update operations, a respective dependency relationship of the word to be processed and a respective confidence level corresponding to the dependency relationship is determined, and a respective update of the set of words to be processed is performed.